Navigation Links
Allegheny General Hospital Launches Study to Determine Best Practices for Treating Epilepsy in the Emergency Room
Date:8/12/2015

Allegheny General Hospital, part of the Allegheny Health Network, is one of 39 medical centers across the United States participating in a clinical trial to help determine better ways to treat patients with prolonged seizures in Emergency Departments.

Currently, there is not a standardized protocol for emergency treatment of Status Epilepticus (SE), a seizure or recurrent seizures lasting longer than five minutes without stopping or waking up. A person whose seizure doesn’t stop after receiving a full dose of medicine designed to stop seizures is considered to have Established Status Epilepticus (ESE).

The Established Status Epilepticus Treatment Trial (ESETT) will study three commonly used medicines given in the Emergency Department for ESE, phenoytoin, valproic acid and levetiracetam, to determine which of these is safest and most effective.

“Physicians use their best judgment to treat seizures in an emergency setting, but there currently is no substantial clinical evidence to show that one medication stands out above the rest,” said Andrea Synowiec, DO, principal investigator of the study at Allegheny General.

“The data that we collect in the ESETT Trial will enable physicians to determine best practices and create a standard protocol for emergency treatment of ESE that will yield the best possible outcomes for patients, no matter where they are treated.”

Prolonged seizures can happen to people of any age, affecting the ability to think and remember, function normally and live independently. In serious cases, SE may limit awareness or cause coma, permanent brain damage or death. There are approximately 120,000 to 180,000 episodes of SE each year in the United States.

The ESETT trial will involve any patient 2 years or older with an active recurrent or ongoing seizure lasting longer than five minutes which fails to respond to a full dose of medication that should stop it. Patients will randomly receive one of the three study medications and blood samples may be taken. If the seizure does not stop, physicians will give extra medication, which could be one of the three study drugs or a different medication.

Because a person having a seizure is unable to provide consent to participate in research and the requirement of timely treatment makes it impossible to get consent from the patient’s family, patients will be enrolled without consent. This Exception from Informed Consent is lifted once the patient wakes up or his or her legal representative is located and the study team can inform them about the trial and request permission to continue in the study.

The ESETT study is part of the Neurological Emergencies Treatment Trials and Pediatric Emergency Care & Applied Research Network, which are funded by the National Institutes of Health. In addition to Allegheny General Hospital, UPMC Presbyterian Hospital and Children’s Hospital of Pittsburgh will also enroll patients in the ESETT trial.
To learn more about the study, including the opportunity to decline participation, visit http://www.esett.org or call 412.359.5075.

About Allegheny General Hospital
Allegheny General Hospital’s Neuroscience Program has long been regarded as one of the nation’s leading referral centers for the treatment of brain injuries and complex neurological diseases, including epilepsy. The Comprehensive Epilepsy Program at AGH was established in 1987 and has become one of the largest such services in the tri-state area. Along with diagnostic expertise, the program offers advanced medical and surgical treatments for epilepsy. AGH is a member of the National Association of Epilepsy Centers and has earned the Association’s highest Level 4 designation.

Read the full story at http://www.prweb.com/releases/2015/08/prweb12901465.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program
2. Allegheny Health Network Research Confirms Value of Less-Invasive POEM Procedure For Wider Range of Esophageal Disorders
3. Allegheny Health Network's Susan Manzi, MD, Receives National Lupus Advocacy Award
4. Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech
5. Allegheny General Hospital Introduces New Treatment for Relapsing Multiple Sclerosis
6. Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue
7. Allegheny Health Network Transplant Team Participates in Nation’s Largest Multi-State Paired Kidney Exchange
8. Western Pennsylvania’s First Robotic-Assisted Hip and Knee Surgeries Performed at Allegheny Health Network’s West Penn Hospital
9. Nationally-Recognized Cleveland Clinic Foot and Ankle Surgeon, James J. Sferra, MD, to Lead Allegheny Health Network Program
10. Allegheny Health Network Physician Research Points to Possible New Paradigm in Ovarian Cancer Treatment
11. Allegheny General Hospital Performs Milestone Transcatheter Aortic Valve Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... Agreements being discussed by President Donald Trump and the rest of the world. Donald ... up peace talks in the continuous battle between Israel and Palestine. The world’s eyes ...
(Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as host and ... the series is on hiking in American. Viewers can reconnect with America as it ... of hiking. , Many consumers have looked for an inventive new place for a ...
(Date:5/26/2017)... ... , ... “When the Stars Lead Home”: a poignant story of loss, determination, ... Weigel Douglas, an avid reader who lives in the Pacific Northwest with her husband, ... Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year old Tizzy could not ...
(Date:5/26/2017)... ... May 26, 2017 , ... Centennial-based BluSky Restoration Contractors ... its 14th Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, ... , As part of BluSky’s partnership with The Adoption Exchange, BluSky will also ...
(Date:5/26/2017)... ... ... Jack: Against All Odds”: the story of Coach Cactus Jack and the impact he ... creation of published author, Walter Hubbard, a retired wildlife and fisheries biologist and pharmacy ... Walter and Jane have three adult children and a granddaughter. Walter and ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/10/2017)... 2017 Hologic, Inc. (Nasdaq: HOLX ... fiscal second quarter ended April 1, 2017 .   ... 666.7% compared to the prior year period as the ... significant gain, while non-GAAP diluted EPS of $0.50 increased ... in constant currency terms.  Excluding the effects of blood ...
(Date:5/9/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... has earned a spot on Forbes, "America,s ... ranked among 500 U.S. employers as well as in ... Services. The annual Forbes rankings ... of over 30,000 employees across 25 industries. The survey ...
Breaking Medicine Technology: